Precigen Reports Full Year 2023 Financial Results and Business Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil settles down after choppy session as investors weigh Hormuz talks
- Meta to pay up to $16.68 billion in mass social media settlement
- Anthropic agrees to $45bn cloud computing deal with Nscale - report
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
- NVIDIA (NVDA) Tops Q2 EPS by 14c, Offers Guidance
JMP Securities Reiterates Market Outperform Rating on Precigen Inc. (PGEN)
March 20, 2024 3:16 PM EDTJMP Securities analyst Jason N. Butler reiterated a Market Outperform rating and $14.00 price target on Precigen Inc. (NASDAQ: PGEN).
The analyst commented, "Focus on upcoming pivotal results for PRGN-2012 in RRP; we reiterate our Market Outperform rating and $14 risk-adjusted, sum-of-the-parts-derived price target on Precigen.... More
